Yahoo Finance

PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy

WASHINGTON, March 24, 2026 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, ...
Yahoo Finance

PPMD Provides $400,000 in Funding to MyoGene Bio Through PPMD Venture Pathways Program to Support Development of Gene Editing Platform

WASHINGTON, Nov. 4, 2025 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the largest U.S. non-profit leading Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and ...
EurekAlert!

PPMD awards $600,000 to NJIT and Talem for Duchenne muscular dystrophy exoskeleton

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced a $600,000 grant to be awarded to the New Jersey ...
Business Wire

Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...
Business Wire

PerkinElmer Provides Newborn Screening Solution for Duchenne Muscular Dystrophy as part of PPMD’s New York State Pilot Program

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it is providing the newborn screening assay for Parent Project ...
Financial Post

Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled “Research Row: PPMD Moving the Needle” on June 29, 2024 – TORONTO — Satellos Bioscience Inc. (“Satellos” or the “Company”) ...